|
|
H2009/20683/318/R1
|
ACTEMRA 400MG
|
TOCILIZUMAB
|
F. HOFFMAN-LA ROCHE LTD
|
Retained
|
Details →
|
|
|
H2009/20681/319/R1
|
ACTEMRA 80MG
|
TOCILIZUMAB
|
F. HOFFMAN-LA ROCHE LTD
|
Retained
|
Details →
|
|
|
H2019/CTD4401/483ER/R1
|
DNS
|
ANHYDROUS GLUCOSE AND SODIUM CHLORIDE INTRAVENOUS…
|
Abacus Pharma (A) Ltd
|
Retained
|
Details →
|
|
|
H2008/19372/407/R1
|
DOXOL 20 mg/0.5 ml Injection
|
Docetaxel
|
Venus Remedies Limited
|
Retained
|
Details →
|
|
|
H2004/149 (13757)/R1
|
Dopamine HCl Fresenius Solution for Infusion
|
Dopamine Hydrochloride
|
Fresenius Kabi Manufacturing SA (Pty) Limited
|
Retained
|
Details →
|
|
|
16830; H2005/465/R1
|
Leflox IV 500 mg Injection
|
Levofloxacin
|
Getz Pharma (Pvt) Limited
|
Retained
|
Details →
|
|
|
H2005/465/16830/R1
|
Leflox IV 500 mg Injection
|
Levofloxacin
|
Getz Pharma (Pvt) Limited
|
Retained
|
Details →
|
|
|
H2009/19891/468/R1
|
SEDOL 100 mg/5 ml Injection
|
Etoposide USP
|
Venus Remedies Limited
|
Retained
|
Details →
|
|
|
10678/R1
|
Sandostatin Solution 0.05mg/ml
|
Ocreotide acetate
|
Novartis
|
Retained
|
Details →
|
|
|
H2011/10678/R1
|
Sandostatin Solution 0.05mg/ml
|
Ocreotide acetate
|
Novartis
|
Retained
|
Details →
|
|
|
-
|
ZOLENDRONIC ACID AMRING
|
Zolendronic Acid
|
AMRING FARMA SRL
|
Withdrawn Voluntarily by MAH
|
Details →
|